RNA interference mediated in human primary cells via recombinant baculoviral vectors

L J Nicholson, M Philippe, A J Paine, D A Mann, C T Dolphin

Research output: Contribution to journalArticlepeer-review

61 Citations (Scopus)


The success of RNA interference (RNAi) in mammalian cells, mediated by siRNAs or shRNA-generating plasmids, is dependent, to an extent, upon transfection efficiency. This is a particular problem with primary cells, which are often difficult to transfect using cationic lipid vehicles. Effective RNAi in primary cells is thus best achieved with viral vectors, and retro-, adeno-, and lentivirus RNAi systems have been described. However, the use of such human viral vectors is inherently problematic, e.g., Class 2 status and requirement of secondary helper functions. Although insect cells are their natural host, baculoviruses also transduce a range of vertebrate cell lines and primary cells with high efficiency. The inability of baculoviral vectors to replicate in mammalian cells, their Class I status, and the simplicity of their construction make baculovirus an attractive alternative gene delivery vector. We have developed a baculoviral-based RNAi system designed to express shRNAs and GFP from U6 and CMV promoters, respectively. Transduction of Saos2, HepG2, Huh7, and primary human hepatic stellate cells with a baculoviral construct expressing shRNAs targeting lamin A/C resulted in effective knockdown of the corresponding mRNA and protein. Development of this baculoviral-based system provides an additional shRNA delivery option for RNAi-based investigations in mammalian cells
Original languageEnglish
Pages (from-to)638 - 644
Number of pages7
JournalMolecular Therapy
Issue number4
Publication statusPublished - Apr 2005


Dive into the research topics of 'RNA interference mediated in human primary cells via recombinant baculoviral vectors'. Together they form a unique fingerprint.

Cite this